| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.45 | 0.003 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.77 | 0.003 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.004 |